 |
Cisplatin in liposomal formulation |
|---|---|
| Trade Name | Slit Cisplatin For Inhalation |
| Orphan Indication | Pediatric osteosarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2007-03-20 00:00:00 |
| Sponsor | Eleison Pharmaceuticals LLC;263 13th Avenue, Suite 375;St. Petersburg, Florida, 33701 |
